ACCELERON PHARMA INC. Increase (Decrease) in Contract with Customer, Liability
ACCELERON PHARMA INC. reported Increase (Decrease) in Contract with Customer, Liability of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2019-02-27
- ACCELERON PHARMA INC. increase (decrease) in contract with customer, liability for the quarter ending 2018-12-31 was $0.00.
- ACCELERON PHARMA INC. increase (decrease) in contract with customer, liability for the quarter ending 2018-09-30 was $0.00.
- ACCELERON PHARMA INC. increase (decrease) in contract with customer, liability for the quarter ending 2017-12-31 was -$136.00K.
- ACCELERON PHARMA INC. increase (decrease) in contract with customer, liability for the quarter ending 2017-09-30 was -$135.00K.
- ACCELERON PHARMA INC. increase (decrease) in contract with customer, liability for fiscal 2018 was $0.00.
- ACCELERON PHARMA INC. increase (decrease) in contract with customer, liability for fiscal 2017 was -$543.00K.
- ACCELERON PHARMA INC. increase (decrease) in contract with customer, liability for fiscal 2016 was -$549.00K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $0.00 derived: sum of 2 quarters · filed 2019-02-27 | $0.00 10-K · filed 2019-02-27 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $0.00 10-Q · filed 2018-10-30 | ||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-02 | |||
| 2017-12-31 | -$136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$271.00K derived: sum of 2 quarters · filed 2019-02-27 | -$543.00K 10-K · filed 2019-02-27 | |
| 2017-09-30 | -$135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | -$407.00K 10-Q · filed 2018-10-30 | ||
| 2017-06-30 | -$272.00K 10-Q · filed 2018-08-02 | |||
| 2016-12-31 | -$549.00K 10-K · filed 2019-02-27 |